Neurocrine Biosciences
Neurology and Endocrinology Research and Therapy | Neurocrine Biosciences.
Launch date
Employees
Market cap
CAD16.7b
Enterprise valuation
CAD15.6b (Public information from Sep 2024)
Share price
$120.46 NBIX
San Diego California (HQ)
Authorizing premium user...